Vigabatrin Powder, For Solution
Product Images NDC 69097-964

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 69097-964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vigabatrin (Vigabatrinsol Fig1)

Chemical structure of vigabatrin shown as a molecular diagram with labeled functional groups including an amino group, a vinyl group, and a carboxylic acid group.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig10)

An instructional image showing a hand holding an oral dosing syringe marked from 1 mL to 10 mL in increments of 1 mL. The syringe is likely used for measuring and administering a liquid medication, such as vigabatrin oral solution.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig11)

An instructional illustration showing a hand holding a dosing syringe filled with liquid above a clear glass, likely demonstrating the oral administration or measurement of a powdered drug solution for VIGABATRIN 500 mg/mL.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig12)

An instructional illustration labeled Figure G shows a hand holding a spoon stirring a clear solution inside a glass tumbler. The image appears to demonstrate preparation or mixing, consistent with the oral powder-for-solution dosage form of Vigabatrin 500 mg/mL.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig13)

An illustration showing a hand holding a syringe partially submerged in a clear liquid inside a glass, demonstrating a step likely related to preparation or measurement of the oral solution for VIGABATRIN 500 mg/mL powder for solution.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig14)

An instructional image showing a hand holding a small clear oral dosing syringe with volume measurements marked in milliliters. This syringe is used for measuring the oral solution of Vigabatrin 500 mg/mL powder for solution, a prescription drug by Cipla USA, Inc.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig15)

Image showing an adult administering oral medication to a child using an oral dosing syringe. The child is seated and opening their mouth to receive the medicine.*

FDA Label Image

Pouch Label Front Side (Vigabatrinsol Fig16)

Vigabatrin 500 mg powder for oral solution label by Cipla USA, Inc. This label includes the proprietary name Vigabatrin, strength 500 mg, and indicates it is for oral solution USP. It states the product is prescription only (Rx Only) with the NDC 69097-964-53. Instructions include mixing with water immediately before use. The label features Cipla's logo and contact information for the manufacturer in Hauppauge, NY.*

FDA Label Image

Carton Label (Vigabatrinsol Fig18)

Packaging label for Vigabatrin powder for oral solution, USP 500 mg per packet by Cipla USA, Inc. The carton contains 50 packets. Directions instruct mixing each packet with 10 mL of water prior to administration. The label includes storage instructions, manufacturer details, and a barcode.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig2)

A cumulative percentage plot showing the percent reduction in seizure frequency versus percent of patients. The graph includes four lines representing placebo and three vigabatrin dosages (1 g/day, 3 g/day, 6 g/day), illustrating the distribution of seizure frequency changes categorized by improvement, no change, and worsening.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig3)

Kaplan-Meier type cumulative frequency graph showing percentage reduction in seizure frequency versus percentage of patients. Two curves compare placebo and 3 g/day Vigabatrin treatment groups, illustrating seizure frequency changes ranging from worsening to improvement.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig4)

Vigabatrin 500 mg/mL powder for oral solution carton label from Cipla USA, Inc. The image shows the product label on a clear container alongside two white dosing syringes, a glass with a spoon, a glass with a prepared clear liquid solution, and a pair of small black scissors on a white background.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig5)

Illustration of an oral syringe showing labeled parts including tip, dosage indicators, barrel, bottom of white plunger, and plunger. This diagram highlights the components of an oral dosing device typically used for administering liquid medications.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig6)

Illustration showing a hand holding a sachet of VIGABATRIN 500 mg/mL powder for solution, being poured into a glass, demonstrating preparation for oral administration.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig7)

An image labeled Figure B showing two clear drinking glasses side by side. The glass on the left is filled with water, while the glass on the right is empty. This likely illustrates a step or comparison related to preparing an oral solution of Vigabatrin powder.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig8)

Illustration showing a hand holding a syringe with measurement markings, partially immersed in a glass of clear liquid, likely demonstrating the preparation or measurement of an oral solution of Vigabatrin powder.*

FDA Label Image

Vigabatrin (Vigabatrinsol Fig9)

An illustration showing a hand holding a small graduated oral syringe, likely used for measuring and administering liquid medicine doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.